Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
暂无分享,去创建一个
W. Busse | W. Calhoun | H. Kita | J. Abrams | J. Sedgwick | G. Gleich | B. Volovitz | G. Gleich | L. Schwartz | M. Ben‐Yaakov | Hirohita Kita
[1] R. Folkerth,et al. Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Bousquet,et al. Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.
[3] G. Gleich,et al. Epithelium-dependent contraction of airway smooth muscle caused by eosinophil MBP. , 1990, The American journal of physiology.
[4] L. Schwartz,et al. Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer. Production of monoclonal antibodies recognizing active tryptase. , 1990, Journal of immunology.
[5] W. Busse,et al. The appearance of hypodense eosinophils during interleukin-2 treatment. , 1990, The Journal of allergy and clinical immunology.
[6] J. Abrams,et al. Host-reactive CD4+ and CD8+ T cell clones isolated from a human chimera produce IL-5, IL-2, IFN-gamma and granulocyte/macrophage-colony-stimulating factor but not IL-4. , 1990, Journal of immunology.
[7] G. Gleich. The eosinophil and bronchial asthma: current understanding. , 1990, The Journal of allergy and clinical immunology.
[8] R. Rothlein,et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. , 1990, Science.
[9] W. Owen,et al. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. , 1989, Journal of immunology.
[10] S. Galli,et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines , 1989, The Journal of experimental medicine.
[11] A. Sheffer,et al. Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome , 1989, The Journal of experimental medicine.
[12] K. Chung,et al. Stimulation of degranulation from human eosinophils by platelet-activating factor. , 1989, Journal of immunology.
[13] R. Kyle,et al. IgA-induced eosinophil degranulation. , 1989, Journal of immunology.
[14] A. Kay,et al. The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. , 1988, Journal of immunology.
[15] L. Schwartz,et al. Tryptase levels in nasal-lavage fluid as an indicator of the immediate allergic response. , 1988, The Journal of allergy and clinical immunology.
[16] S. Wenzel,et al. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. , 1988, The American review of respiratory disease.
[17] C. J. Dunn,et al. Development of a prolonged eosinophil-rich inflammatory leukocyte infiltration in the guinea-pig asthmatic response to ovalbumin inhalation. , 1988, The American review of respiratory disease.
[18] J. Gamble,et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.
[19] H. S. Earl,et al. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. , 1987, The New England journal of medicine.
[20] J. Cesbron,et al. Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. , 1986, Journal of immunology.
[21] G. Gleich,et al. The eosinophil and the pathophysiology of asthma. , 1986, The Journal of allergy and clinical immunology.
[22] A. Togias,et al. Inflammatory mediators in late antigen-induced rhinitis. , 1985, The New England journal of medicine.
[23] H. Sluiter,et al. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.
[24] J. Harley,et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. , 1983, Journal of immunology.
[25] R. Bowsher,et al. Rat histamine N-methyltransferase. Quantification, tissue distribution, purification, and immunologic properties. , 1983, The Journal of biological chemistry.
[26] G. Gleich,et al. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein , 1983, The Journal of experimental medicine.
[27] S. Spector,et al. Standardization of bronchial inhalation challenge procedures. , 1975, The Journal of allergy and clinical immunology.